InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (21 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
21
T+90 hit rate
0%
T+90 mean return
-24.5%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Beskrovnaya Oxana, Directrice Scientifique. Insider active across 1 company, notably Dyne Therapeutics, Inc.. Cumulatively, 31 disclosures have been published. Breakdown: 0 buy · 21 sells. Total volume traded: €774k. History available since 20 September 2021. The latest transaction was disclosed on 11 March 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations31 total
2,153 shares@ US$11.382.6% of flowCommon StockSEC:0000950170-25-038726:0
1,094 shares@ US$11.831.4% of flowCommon StockSEC:0000950170-25-035472:0
2,598 shares@ US$13.953.9% of flowCommon StockSEC:0000950170-25-026837:0
2,334 shares@ US$28.127.1% of flowCommon StockSEC:0000950170-24-135571:0
39,100 shares0Common StockSEC:0000950170-24-134070:0
2,856 shares@ US$28.208.7% of flowCommon StockSEC:0000950170-24-127989:0
2,339 shares@ US$34.558.3% of flowCommon StockSEC:0000950170-24-108151:0
2,161 shares@ US$31.897.1% of flowCommon StockSEC:0000950170-24-105517:0
296 shares@ US$46.001.4% of flowCommon StockSEC:0000950170-24-099122:1
2,340 shares@ US$45.0110.8% of flowCommon StockSEC:0000950170-24-099122:0
2,136 shares@ US$31.347.1% of flowCommon StockSEC:0000950170-24-072170:0
30,426 shares@ US$1.033.3% of flowCommon StockSEC:0000950170-24-063737:0
2,222 shares@ US$28.206.6% of flowCommon StockSEC:0000950170-24-062080:0
2,081 shares@ US$25.705.6% of flowCommon StockSEC:0000950170-24-030443:0
2,373 shares@ US$25.856.4% of flowCommon StockSEC:0000950170-24-029615:0
45,326 shares@ US$1.034.9% of flowCommon StockSEC:0000950170-24-002279:0
1,467 shares@ US$10.721.7% of flowCommon StockSEC:0001209191-23-058326:0
93,718 shares0Common StockSEC:0001209191-23-055521:0
1,436 shares@ US$9.4110.9% of flowCommon StockSEC:0001209191-23-050168:0
1,484 shares@ US$10.411.6% of flowCommon StockSEC:0001209191-23-049356:0
1,475 shares@ US$12.431.9% of flowCommon StockSEC:0001209191-23-037163:0
1,416 shares@ US$13.332.0% of flowCommon StockSEC:0001209191-23-018977:0
40,000 shares0Common StockSEC:0001209191-22-060964:0
1,413 shares@ US$13.702.2% of flowCommon StockSEC:0001209191-22-050881:0
712 shares@ US$14.051.1% of flowCommon StockSEC:0001209191-22-050117:0
25 of 31 declarations
About Beskrovnaya Oxana
Oxana Beskrovnaya is the Chief Scientific Officer at Dyne Therapeutics, Inc. She oversees research and development initiatives, focusing on scientific innovation. Her role is essential in guiding research strategy and ensuring the success of development projects.
